新闻稿

Intrasense announces its participation in RSNA 2024, the world's leading medical imaging congress

6 11 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces its participation in the RSNA 2024 international imaging congress. Intrasense will be showcasing its new Liflow® solution, as well as the innovations of the new version of Myrian®, on the stand of its partner Guerbet, symbolizing a collaboration serving excellence in medical imaging at a global level.

发现更多

Liflow®, a solution dedicated to oncology imaging, wins the JFR 2024 Innovation Prize in the “Healthcare IT and AI” category

30 9 月 2024

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and the developer of Myrian® and Liflow®, is proud to announce that its Liflow® solution has been awarded the Prix Innovation JFR (Journées Francophones de la Radiologie) 2024 in the “Healthcare IT and AI” category.

发现更多

Intrasense announces its half-year results for 2024

25 9 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® et Liflow®, announces its consolidated IFRS half-year results for 2024.

发现更多

Guerbet and Intrasense announce the CE marking of DUOnco™ Liver, an artificial intelligence algorithm designed to detect focal liver lesions

23 9 月 2024

Guerbet (FR0000032526 GBT), worldwide leader in medical imaging, and Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announce the CE marking under MDR of the liver AI developed by Guerbet (trading name: DUOnco™ Liver).

发现更多

Intrasense attends the « Journées Francophones de Radiologie » 2024

9 9 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and Myrian® and Liflow® developer, announces its attendance in Journées Francophones de Radiologie (JFR) 2024, where will be presented for the first time the new solution Liflow® as well as the innovations of the new version of Myrian®.

发现更多

Alexandre Salvador appointed CEO of Intrasense to accelerate strategic repositioning on high value-added medical solutions integrating AI in radiology

27 8 月 2024

The Board of Directors of Intrasense (FR0011179886 - ALINS), metting on August, 28 2024 at 5:30 pm under the chairmanship of Mr. François NICOLAS, has decided to appoint Mr. Alexandre SALVADOR as Chief Executive Officer of Intrasense.

发现更多

Intrasense announces its 2024

25 7 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow® (the "Company"), today announced its half-year revenue for 2024 IFRS consolidated at Group level.

发现更多

Intrasense presents its AI innovations at the SIRM congress in Italy

10 6 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces its participation in SIRM, the congress organized by the Italian Society of Medical and Interventional Radiology, to be held from June 20 to 23 in Milan (Italy).

发现更多

Intrasense announces CE certification of Liflow® to the new European regulation (MDR)

29 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, is proud to announce that the company has obtained CE certification under MDR (European Union Medical Device Regulation 2017/745), for the first version of its Liflow® solution.

发现更多

Intrasense announces the appointment of Jérôme Thiebaud as Chief Business Officer

24 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces the appointment of Jérôme Thiebaud as the Group's Chief Business Officer.

发现更多
订阅